Home › Funds › Palo Alto Investors LP › RARE

Palo Alto Investors LP position in RARE

ULTRAGENYX PHARMACEUTICAL IN · Health Care

Palo Alto Investors LP reported holding 710,029 shares of RARE (ULTRAGENYX PHARMACEUTICAL IN) in its Q3 2026 13F filing — a position valued at US$10.7M, representing 1.59% of its reported portfolio and ranking #19 among its reported holdings. Palo Alto Investors LP has disclosed RARE holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)710.03K sh
Reported value held$10.67M
Portfolio Weight1.59%
First reportedQ2 2025
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Palo Alto Investors LP's RARE position evolved

Palo Alto Investors LP first disclosed a stake in RARE in Q2 2025 at 48,750 shares (US$1.8M). The position peaked in Q2 2026 at 596,495 shares, worth US$19.9M. Across 6 filings, Palo Alto Investors LP increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 710,029 shares valued at US$10.7M — an increase of 113,534 shares quarter over quarter.. Notable position changes include a 658% increase in Q3 2025 (shares fell 24% over the following quarter), a 29% increase in Q1 2026 (shares rose 59% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 48.75K $1.77M New
Q3 2025 369.53K $11.12M Add
Q4 2025 461.29K $10.61M Add
Q1 2026 596.50K $12.50M Add
Q2 2026 596.50K $19.92M Hold
Q3 2026 710.03K $10.67M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RARE and 13F data

RARE (ULTRAGENYX PHARMACEUTICAL IN) is a Health Care company. 14 other funds we track also report a position in RARE — the largest reported positions include RTW INVESTMENTS, LP (US$128.2M), Nantahala Capital Management, LLC (US$35.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RARE

All RARE fund holders →

FAQ

How long has Palo Alto Investors LP held RARE?

Palo Alto Investors LP has disclosed RARE holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Palo Alto Investors LP's current position in RARE?

As of Q3 2026, Palo Alto Investors LP holds 710.03K shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), valued at $10.67M, representing 1.59% of its reported portfolio and ranking #19.

Has Palo Alto Investors LP been buying or selling RARE?

In the latest 13F filing (Q3 2026), Palo Alto Investors LP increased its position in RARE. The position peaked in Q2 2026 at 596.50K shares.

Which other funds hold RARE?

Other major institutional holders of RARE include RTW INVESTMENTS, LP, Nantahala Capital Management, LLC, among 14 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.